⌘K

Login Start Free

Home/Filings/4/0000899243-23-005140

4//SEC Filing

Kearns Evan 4

Accession 0000899243-23-005140

CIK 0001622229other

View on SEC.gov Company Profile

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 3:51 PM ET

Size

5.5 KB

Accession

0000899243-23-005140

Insider Transaction Report

Form 4

Period: 2023-02-13

Cogent Biosciences, Inc.COGT

Chief Legal Officer

Transactions

Award
Stock Option (Right to Buy)
2023-02-13+140,000→ 140,000 total
Exercise: $13.63Exp: 2033-02-13→ Common Stock (140,000 underlying)

Footnotes (1)

[F1]This stock option shall vest in equal monthly installments over a four year period.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cogent Biosciences, Inc.

CIK 0001622229

Entity typeother

Related Parties

1

filerCIK 0001745285

Filing Metadata

Form type: 4
Filed: Feb 14, 7:00 PM ET
Accepted: Feb 15, 3:51 PM ET
Size: 5.5 KB

View on SEC.gov